Atossa Therapeutics and Quantum Leap Healthcare Announce I-SPY 2 Clinical Trial to Evaluate (Z)-Endoxifen in Combination with Abemaciclib (VERZENIO®) in Women with ER+/HER2- Breast Cancer

9d ago

ATOS

PremiumPress Releases

Atossa to Participate in Noble Capital Markets Emerging Growth Healthcare Conference

13d ago

ATOS

PremiumPress Releases

Atossa Therapeutics Presents Data from 40mg Cohort of Phase 2 EVANGELINE Clinical Trial Showing 100% Disease Control Rate After 24-Weeks of Treatment with (Z)-Endoxifen

15d ago

ATOS

PremiumCompany Announcements

Navigating Choppy Waters: Atossa Therapeutics’ Struggle with Compliance Costs and Business Performance

21d ago

ATOS

PremiumPress Releases

Atossa Therapeutics Announces Year-End 2023 Financial Results and Provides Corporate Update

23d ago

ATOS

PremiumPre-Earnings

Is ATOS a Buy, Before Earnings?

29d ago

ATOS

PremiumPress Releases

Atossa Therapeutics Provides Five-Year (Z)-Endoxifen Treatment Update on FDA-Approved “Expanded Access” Program for a U.S. Breast Cancer Patient

1M ago

ATOS

More ATOS News >

ATOS News on the Web

2024-04-15

Atossa Therapeutics announces breast cancer trial evaluating lead asset in combination with Eli Lill

Proactive Investors

Neutral

2024-04-15

Atossa Therapeutics announces breast cancer trial evaluating lead asset in combination with Eli Lill

Proactive Investors

Neutral

2024-04-15

Atossa Therapeutics and Quantum Leap Healthcare Announce I-SPY 2 Clinical Trial to Evaluate in Women with ER+/HER2- Breast Cancer

Yahoo Finance

Neutral

2024-04-11

Atossa (ATOS) Reports Positive Results From EVANGELINE Study

Zacks

Neutral

2024-04-11

Atossa to Participate in Noble Capital Markets Emerging Growth Healthcare Conference

Yahoo Finance

Neutral

2024-04-10

Atossa Therapeutics Poised for Growth with Promising Breast Cancer Treatment

TipRanks News

Bullish

2024-04-09

Atossa Therapeutics reports positive data from breast cancer treatment trial

Proactive Investors

Neutral

2024-04-09

Atossa Therapeutics reports positive data from breast cancer treatment trial

Proactive Investors

Neutral

News Score - Last 7 Days

Not enough data to generate a sentiment score

Media Buzz

This Week0 articles

Weekly Average0 articles

News Sentiment

Currently, no data available

See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is ATOS’s Media Buzz Sentiment?

Currently, no data Available

What is ATOS’s weekly average amount of articles?

Currently, no data Available

What is ATOS’s News Sentiment?

Currently, no data Available

Healthcare Stocks that are Trending in the News

DAWNDay One Biopharmaceuticals

IMVTImmunovant

RVVRevive Therapeutics

NVSNovartis

ISRGIntuitive Surgical

Showing the stocks with the most bullish news sentiment over the past week

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing